BioGaia AB (publ)
BIOGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -8.23 | -12.62 | 0.26 | 5.74 |
| FCF Yield | 3.21% | 3.79% | 3.37% | 2.13% |
| EV / EBITDA | 18.51 | 18.51 | 15.65 | 31.27 |
| Quality | ||||
| ROIC | 18.10% | 16.09% | 14.72% | 9.86% |
| Gross Margin | 72.45% | 73.29% | 72.64% | 74.25% |
| Cash Conversion Ratio | 0.88 | 0.96 | 0.88 | 0.87 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.82% | 18.20% | 13.90% | 0.72% |
| Free Cash Flow Growth | -4.82% | 25.32% | 39.69% | 5.03% |
| Safety | ||||
| Net Debt / EBITDA | -2.21 | -3.37 | -3.08 | -5.33 |
| Interest Coverage | 28.37 | 547.72 | 67.11 | 224.15 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 1.91 | 2.11 | 1.97 |
| Cash Conversion Cycle | 3.71 | 170.72 | 204.55 | 164.23 |